Filed: 2/6/2025ACC: 0001104659-25-010152
📋 What this filing means
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $819.65M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$819.65M
Total AUM (reported)
56.80M
Total Shares
Allocation by class
COMMON STOCK$819.65M100.0%
Portfolio Concentration
Top 3$545.02M66.5%
4–10$265.93M32.4%
11–25$8.70M1.1%
Top 3 weight
66.5%
Top 10 weight
98.9%
Voting Authority Distribution
Total shares with voting rights: 56.80M
Sole
Full voting authority
56.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
Kymera Therapeutics, Inc.
SOLEShares4.90M
TypeSH
Market value$196.98M
24.03%
Sole
4.90M
Shared
0.00
None
0.00
Dyne Therapeutics, Inc.
SOLEShares8.02M
TypeSH
Market value$188.94M
23.05%
Sole
8.02M
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares2.51M
TypeSH
Market value$159.10M
19.41%
Sole
2.51M
Shared
0.00
None
0.00
Third Harmonic Bio, Inc.
SOLEShares10.40M
TypeSH
Market value$107.04M
13.06%
Sole
10.40M
Shared
0.00
None
0.00
Day One Biopharmaceuticals, Inc.
SOLEShares6.43M
TypeSH
Market value$81.47M
9.94%
Sole
6.43M
Shared
0.00
None
0.00
Korro Bio, Inc.
SOLEShares1.14M
TypeSH
Market value$43.29M
5.28%
Sole
1.14M
Shared
0.00
None
0.00
Vigil Neuroscience, Inc.
SOLEShares5.84M
TypeSH
Market value$9.92M
1.21%
Sole
5.84M
Shared
0.00
None
0.00
Generation Bio, Co.
SOLEShares8.28M
TypeSH
Market value$8.78M
1.07%
Sole
8.28M
Shared
0.00
None
0.00
Ikena Oncology, Inc.
SOLEShares5.02M
TypeSH
Market value$8.23M
1.00%
Sole
5.02M
Shared
0.00
None
0.00
Q32 Bio, Inc.
SOLEShares2.09M
TypeSH
Market value$7.20M
0.88%
Sole
2.09M
Shared
0.00
None
0.00
Aerovate Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$4.77M
0.58%
Sole
1.80M
Shared
0.00
None
0.00
Tectonic Therapeutics, Inc.
SOLEShares78.45K
TypeSH
Market value$3.62M
0.44%
Sole
78.45K
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares305.25K
TypeSH
Market value$314.4K
0.04%
Sole
305.25K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc.SOLE | Common Stock | 4.90M | SH | $196.98M 24.03% | 4.90M | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | Common Stock | 8.02M | SH | $188.94M 23.05% | 8.02M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | Common Stock | 2.51M | SH | $159.10M 19.41% | 2.51M | 0.00 | 0.00 |
Third Harmonic Bio, Inc.SOLE | Common Stock | 10.40M | SH | $107.04M 13.06% | 10.40M | 0.00 | 0.00 |
Day One Biopharmaceuticals, Inc.SOLE | Common Stock | 6.43M | SH | $81.47M 9.94% | 6.43M | 0.00 | 0.00 |
Korro Bio, Inc.SOLE | Common Stock | 1.14M | SH | $43.29M 5.28% | 1.14M | 0.00 | 0.00 |
Vigil Neuroscience, Inc.SOLE | Common Stock | 5.84M | SH | $9.92M 1.21% | 5.84M | 0.00 | 0.00 |
Generation Bio, Co.SOLE | Common Stock | 8.28M | SH | $8.78M 1.07% | 8.28M | 0.00 | 0.00 |
Ikena Oncology, Inc.SOLE | Common Stock | 5.02M | SH | $8.23M 1.00% | 5.02M | 0.00 | 0.00 |
Q32 Bio, Inc.SOLE | Common Stock | 2.09M | SH | $7.20M 0.88% | 2.09M | 0.00 | 0.00 |
Aerovate Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $4.77M 0.58% | 1.80M | 0.00 | 0.00 |
Tectonic Therapeutics, Inc.SOLE | Common Stock | 78.45K | SH | $3.62M 0.44% | 78.45K | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 305.25K | SH | $314.4K 0.04% | 305.25K | 0.00 | 0.00 |